Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis
暂无分享,去创建一个
A. Qian | Ye Tian | Xiao Lin | Zhihao Chen | Xiaoni Deng | Qiang Hao | Kewen Zhang | Hui Zhang | W. Qiu | Fang Xu | Meng Li
[1] Hong-xia Fan,et al. Celastrol Attenuates RANKL-Induced Osteoclastogenesis in vitro and Reduces Titanium Particle-Induced Osteolysis and Ovariectomy-Induced Bone Loss in vivo , 2021, Frontiers in Pharmacology.
[2] Ying-Xing Xu,et al. Icariin stimulates osteogenesis and suppresses adipogenesis of human bone mesenchymal stem cells via miR-23a-mediated activation of the Wnt/β-catenin signaling pathway. , 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[3] F. Caradonna,et al. Flavonoids in Bone Erosive Diseases: Perspectives in Osteoporosis Treatment , 2020, Trends in endocrinology and metabolism.
[4] S. Mani,et al. Acacetin Ameliorates Experimental Colitis in Mice via Inhibiting Macrophage Inflammatory Response and Regulating the Composition of Gut Microbiota , 2021, Frontiers in Physiology.
[5] D. Ilchovska,et al. An overview of the NF-kB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-kB ligand RANKL and related nutritional interventions. , 2020, Autoimmunity reviews.
[6] Jiacan Su,et al. Targeting actin-bundling protein L-plastin as an anabolic therapy for bone loss , 2020, Science Advances.
[7] Xiang Xue,et al. Acacetin Induces Apoptosis in Human Osteosarcoma Cells by Modulation of ROS/JNK Activation , 2020, Drug design, development and therapy.
[8] Weiyi Chen,et al. Silencing of miR-138-5p sensitizes bone anabolic action to mechanical stimuli , 2020, Theranostics.
[9] Kangmao Huang,et al. Acacetin Suppresses IL-1β-Induced Expression of Matrix Metalloproteinases in Chondrocytes and Protects against Osteoarthritis in a Mouse Model by Inhibiting NF-κB Signaling Pathways , 2020, BioMed research international.
[10] Xiaojuan He,et al. Potential Advantages of Bioactive Compounds Extracted From Traditional Chinese Medicine to Inhibit Bone Destructions in Rheumatoid Arthritis , 2020, Frontiers in Pharmacology.
[11] S. Lim,et al. Linarin and its aglycone acacetin abrogate actin ring formation and focal contact to bone matrix of bone-resorbing osteoclasts through inhibition of αvβ3 integrin and core-linked CD44. , 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[12] Xiaoke Zheng,et al. Acacetin improves endothelial dysfunction and aortic fibrosis in insulin-resistant SHR rats by estrogen receptors , 2020, Molecular Biology Reports.
[13] W. Haibin,et al. Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation. , 2020, Pharmacological research.
[14] Hongbo He,et al. Positive Effect of Gushukang on Type-H Vessel and Bone Formation , 2020, Frontiers in Cell and Developmental Biology.
[15] Jinglong Yan,et al. Nuciferine prevents bone loss by disrupting multinucleated osteoclast formation and promoting type H vessel formation , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[16] Wei Zhang,et al. Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity. , 2019, Biochemical pharmacology.
[17] B. Mitlak,et al. Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis , 2019, The Journal of clinical endocrinology and metabolism.
[18] A. Qian,et al. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway , 2019, Molecular and Cellular Endocrinology.
[19] Shouan Zhu,et al. Macrophage-lineage TRAP+ cells recruit periosteum-derived cells for periosteal osteogenesis and regeneration. , 2019, The Journal of clinical investigation.
[20] Huarong Huang,et al. Circulating miR-338 Cluster activities on osteoblast differentiation: Potential Diagnostic and Therapeutic Targets for Postmenopausal Osteoporosis , 2019, Theranostics.
[21] Kuo-Hu Chen,et al. Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions , 2019, International journal of molecular sciences.
[22] M. Cross,et al. The Cost of Osteoporosis, Osteopenia, and Associated Fractures in Australia in 2017 , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[23] Changjun Li,et al. The association between CD31hiEmcnhi endothelial cells and bone mineral density in Chinese women , 2019, Journal of Bone and Mineral Metabolism.
[24] P. Lips,et al. The effect of raloxifene on bone marrow adipose tissue and bone turnover in postmenopausal women with osteoporosis. , 2017, Bone.
[25] Ping Yang,et al. Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice. , 2018, Bone.
[26] Jiacan Su,et al. 18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL-Mediated RANK–TRAF6 Interactions and NF-κB and MAPK Signaling Pathways , 2018, Front. Pharmacol..
[27] T. Nakashima,et al. Recent advances in osteoclast biology , 2018, Histochemistry and Cell Biology.
[28] P. Zhang,et al. Human type H vessels are a sensitive biomarker of bone mass , 2017, Cell Death & Disease.
[29] C. Bigot,et al. α-1 Antitrypsin Inhibits RANKL-induced Osteoclast Formation and Functions , 2017, Molecular medicine.
[30] L. Hao,et al. Gα13 negatively controls osteoclastogenesis through inhibition of the Akt-GSK3β-NFATc1 signalling pathway , 2017, Nature Communications.
[31] M. Bixel,et al. Blood flow controls bone vascular function and osteogenesis , 2016, Nature Communications.
[32] Weiguo Zou,et al. Inactivation of Regulatory-associated Protein of mTOR (Raptor)/Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice* , 2016, The Journal of Biological Chemistry.
[33] Yuping Zhang,et al. Preparative Purification of Bioactive Compounds from Flos Chrysanthemi Indici and Evaluation of Its Antiosteoporosis Effect , 2016, Evidence-based complementary and alternative medicine : eCAM.
[34] Zhuojing Luo,et al. Gastrodin: an ancient Chinese herbal medicine as a source for anti-osteoporosis agents via reducing reactive oxygen species. , 2015, Bone.
[35] W. Grayson. Faculty Opinions recommendation of PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. , 2015 .
[36] Z.-q. Zhang,et al. Association between dietary intake of flavonoid and bone mineral density in middle aged and elderly Chinese women and men , 2014, Osteoporosis International.
[37] L. Duong,et al. PDGF-BB secreted by preosteoclasts induces CD31hiEmcnhi vessel subtype in coupling osteogenesis , 2014, Nature Medicine.
[38] R. Adams,et al. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone , 2014, Nature.
[39] A. Bode,et al. The P110 subunit of PI3-K is a therapeutic target of acacetin in skin cancer. , 2014, Carcinogenesis.
[40] R. Agarwal,et al. Acacetin Inhibits In Vitro and In Vivo Angiogenesis and Downregulates Stat Signaling and VEGF Expression , 2013, Cancer Prevention Research.
[41] Soo Young Lee,et al. Akt Induces Osteoclast Differentiation through Regulating the GSK3β/NFATc1 Signaling Cascade , 2012, The Journal of Immunology.
[42] Antonia C Hardcastle,et al. Associations between dietary flavonoid intakes and bone health in a scottish population , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[43] Ying-Jan Wang,et al. Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice. , 2006, Biochemical pharmacology.
[44] Hiroshi Takayanagi,et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. , 2002, Developmental cell.
[45] S. Mckercher,et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1 , 1997, Nature.
[46] E. Wagner,et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. , 1994, Science.